"hodgkin lymphoma" trang 2 - tải miễn phí từ tailieuXANH
Relationship between Non-Hodgkin’s lymphoma and blood levels of Epstein-Barr Virus in children in north-western Tanzania: A case control study

Relationship between Non-Hodgkin’s lymphoma and blood levels of Epstein-Barr Virus in children in north-western Tanzania: A case control study
7    43    0
Occupational exposure to formaldehyde and risk of non hodgkin lymphoma: A meta-analysis

Occupational exposure to formaldehyde and risk of non hodgkin lymphoma: A meta-analysis
9    60    0
Multiple secondary cauda equina non Hodgkin’s lymphoma: A case report and literature review

Multiple secondary cauda equina non Hodgkin’s lymphoma: A case report and literature review
5    69    0
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis

Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis
12    64    0
Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
9    92    0
The dose-response relationship between tobacco smoking and the risk of lymphomas: A case-control study

The dose-response relationship between tobacco smoking and the risk of lymphomas: A case-control study
9    120    0
Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis
10    63    0
Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: Correlation with clinical and pathologic findings

Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: Correlation with clinical and pathologic findings
7    37    0
Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma

Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
8    72    0
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: Study design

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: Study design
7    50    0
Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: A case report and review of literature

Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: A case report and review of literature
9    74    0
Sister chromatid cohesion defects are associated with chromosome instability in Hodgkin lymphoma cells

Sister chromatid cohesion defects are associated with chromosome instability in Hodgkin lymphoma cells
10    74    0
GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers

GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
7    103    0
Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma

Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma
13    65    0
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
11    37    1
Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: The first comprehensive report from the Middle East

Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: The first comprehensive report from the Middle East
16    38    1
Primary sacral non - Hodgkin’s lymphoma: A case report

Primary sacral non - Hodgkin’s lymphoma: A case report
5    56    1
Điều trị nhắm đích trong lymphoma không Hodgkin

Điều trị nhắm đích trong lymphoma không Hodgkin
9    43    1
Causes of death and effect of non-cancerspecific death on rates of overall survival in adult classic Hodgkin lymphoma: A populated-based competing risk analysis

Causes of death and effect of non-cancerspecific death on rates of overall survival in adult classic Hodgkin lymphoma: A populated-based competing risk analysis
11    248    1
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma

High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma
8    200    2
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.